Author: Reena Pagnoni

For more information, see: bionj.org/bionj-biopartnering-conference

ArrePath will be attending the 32nd European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Lisbon, Portugal from April 23-26. Learn more.

For more information, see: https://www.massbio.org/align

For more information, see: GRC: New Antibacterial and Development Conference

For more information, see: https://amr-conference.com/program-2024/

For more information, see: Biotech Showcase

ArrePath is looking forward to taking part in BioInfect 2023; Alderley Park Conference Centre, UK, 1st February 2023, where our CEO, Lloyd Payne, will be presenting in the ‘State of the AMR Nation’ panel discussion.

With the WHO declaring AMR one of the top 10 global public health threats facing humanity, a collaborative approach is needed across all sectors. BioInfect 2023 will look at the critical issues relating to the challenges of new anti-infective development, the endemic problem of resistance, and the considerations for creating a truly global and effective response to antimicrobial resistance.

For more information, see: Bionow | 2023 BioInfect Conference

We are pleased to announce that ArrePath has been selected to participate in the first ever @MassBio Innovation Week. We will provide a company overview and update on the application of our AI / ML enabled imaging platform in the discovery of new classes of antibacterials.

MassBio is using their global platform to connect changemakers from underrepresented backgrounds or who are working towards greater health equity/clinical diversity to an audience of prospective partners, investors, stakeholders, and other ecosystem leaders that can help them take the next step with their science.

Learn more about Innovation Week here: https://bit.ly/InnovationWeek22